Sorafekast - Sorafenib 200 mg 30 Tablets (Nexavar) - Anticancer Medication

SORAFENIB 200 mg x (Sorafekast) 30 Tablets

~~$280.00~~ $120.00

Prescription Required

Sorafekast 200mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and certain types of thyroid cancer.

Generic Name	Sorafenib 200 mg
Manufacturer	Aprazer Healthcare Pvt Ltd
Packing	30 Tablets in 1 Bottle
Prescribed For	Liver Cancer, Kidney Cancer and Thyroid Cancer
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of SORAFENIB 200 mg

Targets abnormal cancer cell activity
Helps control cancer development
Supports effective oncology treatment
Used in advanced cancer management
May improve treatment response
Supports better overall health outcomes

Side Effects

Fatigue or weakness
Diarrhea
Loss of appetite
Weight loss
Hand-foot skin reaction (redness, pain, blistering)
Rash or dry skin
Hair thinning or loss
Nausea or vomiting
High blood pressure
Mouth sores

Caution

Take exactly as prescribed.
Do not skip or stop doses.
Inform your doctor of liver, heart, or kidney problems.
Monitor liver function and blood pressure regularly.
Avoid pregnancy during treatment.
Do not share medication.

Sorafenib Price and Reimbursement Information by Country

Sorafenib prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

View Sorafenib medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/sorafenib-specialist-drug/medicinal-forms/
View Sorafenib prescribing information on Drugs.com (USA) – https://www.drugs.com/pro/sorafenib.html
View official Sorafenib prescribing information on DailyMed (USA) – https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dae598f7-823f-405c-ae31-f924594187b9
View Sorafenib reimbursement review information from CDA-AMC (Canada) – https://www.cda-amc.ca/sorafenib-tablets

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.